Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16193258rdf:typepubmed:Citationlld:pubmed
pubmed-article:16193258lifeskim:mentionsumls-concept:C0002736lld:lifeskim
pubmed-article:16193258lifeskim:mentionsumls-concept:C0026187lld:lifeskim
pubmed-article:16193258lifeskim:mentionsumls-concept:C0031928lld:lifeskim
pubmed-article:16193258pubmed:issue4lld:pubmed
pubmed-article:16193258pubmed:dateCreated2005-9-29lld:pubmed
pubmed-article:16193258pubmed:abstractTextRecent studies indicate that minocycline exerts neuroprotective effects in vitro and in vivo, and suggest that the drug may represent a novel therapeutic approach to amyotrophic lateral sclerosis (ALS). In this study we investigated the safety of combined treatment with minocycline and riluzole in ALS. Twenty ALS patients were randomised into two groups and administered either riluzole (50 mg b.i.d.) or riluzole and minocycline (100 mg i.d.) for 6 months. Disease progression was measured by means of the ALS-Functional Rating Scale score at monthly intervals. Respiratory function was measured at the beginning of the study and repeated after 3 and 6 months of treatment. Combined treatment with minocycline and riluzole was not followed by significant side effects. This pilot study shows that minocycline and riluzole can be taken safely together. Further trials are needed to assess efficacy of such treatment.lld:pubmed
pubmed-article:16193258pubmed:languageenglld:pubmed
pubmed-article:16193258pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16193258pubmed:citationSubsetIMlld:pubmed
pubmed-article:16193258pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16193258pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16193258pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16193258pubmed:statusMEDLINElld:pubmed
pubmed-article:16193258pubmed:monthOctlld:pubmed
pubmed-article:16193258pubmed:issn1590-1874lld:pubmed
pubmed-article:16193258pubmed:authorpubmed-author:RicciAAlld:pubmed
pubmed-article:16193258pubmed:authorpubmed-author:PontieriF EFElld:pubmed
pubmed-article:16193258pubmed:authorpubmed-author:ButtarelliF...lld:pubmed
pubmed-article:16193258pubmed:authorpubmed-author:BenincasaDDlld:pubmed
pubmed-article:16193258pubmed:authorpubmed-author:PellicanoCClld:pubmed
pubmed-article:16193258pubmed:issnTypePrintlld:pubmed
pubmed-article:16193258pubmed:volume26lld:pubmed
pubmed-article:16193258pubmed:ownerNLMlld:pubmed
pubmed-article:16193258pubmed:authorsCompleteYlld:pubmed
pubmed-article:16193258pubmed:pagination285-7lld:pubmed
pubmed-article:16193258pubmed:meshHeadingpubmed-meshheading:16193258...lld:pubmed
pubmed-article:16193258pubmed:meshHeadingpubmed-meshheading:16193258...lld:pubmed
pubmed-article:16193258pubmed:meshHeadingpubmed-meshheading:16193258...lld:pubmed
pubmed-article:16193258pubmed:meshHeadingpubmed-meshheading:16193258...lld:pubmed
pubmed-article:16193258pubmed:meshHeadingpubmed-meshheading:16193258...lld:pubmed
pubmed-article:16193258pubmed:meshHeadingpubmed-meshheading:16193258...lld:pubmed
pubmed-article:16193258pubmed:meshHeadingpubmed-meshheading:16193258...lld:pubmed
pubmed-article:16193258pubmed:meshHeadingpubmed-meshheading:16193258...lld:pubmed
pubmed-article:16193258pubmed:year2005lld:pubmed
pubmed-article:16193258pubmed:articleTitleMinocycline in amyotrophic lateral sclerosis: a pilot study.lld:pubmed
pubmed-article:16193258pubmed:affiliationDipartimento di Scienze Neurologiche, II Facoltà di Medicina e Chirurgia, Università di Roma La Sapienza, Clinica Neurologica, Ospedale Sant Andrea, Via di Grottarossa 1035, I-00189 Rome, Italy. francesco.pontieri@ospedalesantandrea.itlld:pubmed
pubmed-article:16193258pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16193258pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:16193258pubmed:publicationTypeRandomized Controlled Triallld:pubmed